{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:37Z","timestamp":1790776837619,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["826JCQN0974"],"award-info":[{"award-number":["826JCQN0974"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008111","name":"Hainan Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["NHXXRCXM202317"],"award-info":[{"award-number":["NHXXRCXM202317"]}],"id":[{"id":"10.13039\/501100008111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","award":["XSTS2025079"],"award-info":[{"award-number":["XSTS2025079"]}],"id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","award":["XSTS2026035"],"award-info":[{"award-number":["XSTS2026035"]}],"id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jep.2026.122201","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:52:39Z","timestamp":1784533959000},"page":"122201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-\u03baB, and SLC22A7 in bile acid metabolism"],"prefix":"10.1016","volume":"372","author":[{"given":"Shi","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifa","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-4472","authenticated-orcid":false,"given":"Aihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jep.2026.122201_bib1","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i8.108730","article-title":"Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: pathophysiology, clinical implications, and emerging therapies","volume":"17","author":"Al-Busafi","year":"2025","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jep.2026.122201_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117385","article-title":"Ethnopharmacologically important highly subsidized Indian medicinal plants: systematic review of their traditional uses, phytochemistry, pharmacology, quality control, conservation status, and future prospects","volume":"320","author":"Anmol","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.jep.2026.122201_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2026.122201_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118358","article-title":"The role of quercetin in the treatment of kidney diseases: a comprehensive review","volume":"190","author":"Chen","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.jep.2026.122201_bib5","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.jep.2026.122201_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1124\/mol.107.043117","article-title":"Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP","volume":"73","author":"Cropp","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jep.2026.122201_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1510080","article-title":"The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications","volume":"15","author":"Du","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.jep.2026.122201_bib8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2026.122201_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118685","article-title":"Exploring the anti-hyperalgesic effects of ethyl gallate in fibromyalgia-like behaviors in mice","volume":"193","author":"Gon\u00e7alves","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.jep.2026.122201_bib10","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jep.2026.122201_bib11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in NASH","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.jep.2026.122201_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.jep.2026.122201_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/13880209.2024.2331060","article-title":"Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1","volume":"62","author":"Li","year":"2024","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jep.2026.122201_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115205","article-title":"The Chinese medicine babaodan suppresses LPS-induced sepsis by inhibiting NLRP3-mediated inflammasome activation","volume":"292","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.122201_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118540","article-title":"Babaodan inhibits cell proliferation and metastasis and enhances anti-tumor effects of camrelizumab by inhibiting M2 phenotype macrophages in hepatocellular carcinoma","volume":"334","author":"Liu","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1186\/s40001-025-03073-6","article-title":"Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions","volume":"30","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"10","key":"10.1016\/j.jep.2026.122201_bib19","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jep.2026.122201_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112301","article-title":"BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats","volume":"249","author":"Lu","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.jep.2026.122201_bib22","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/jpm12071166","article-title":"Combination therapies for nonalcoholic fatty liver disease","volume":"12","author":"Makri","year":"2022","journal-title":"J. Personalized Med."},{"issue":"4","key":"10.1016\/j.jep.2026.122201_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jep.2026.122201_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","article-title":"The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease","volume":"58","author":"Nigam","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10290","key":"10.1016\/j.jep.2026.122201_bib25","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2026.122201_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157607","article-title":"Yujie recipe attenuates bleomycin-induced pulmonary fibrosis via suppressing NF-\u03baB\/NLRP3 signaling in a Nrf2-dependent manner","volume":"150","author":"Qin","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2026.122201_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2026.121475","article-title":"Babaodan alleviates MAFLD through hepatic glycerophospholipid metabolism and PPAR\u03b3\/RXRA\/GPAT3 based on spatial metabolomics and proteomics analysis","volume":"364","author":"Qiu","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.122201_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-026-02990-7","article-title":"MAPK14\/SLC7A11\/GPX4 axis dysregulation drives podocyte ferroptosis via mediating glycerophospholipid metabolism","author":"Qiu","year":"2026","journal-title":"Cell Death Discov."},{"issue":"22","key":"10.1016\/j.jep.2026.122201_bib29","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jep.2026.122201_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jep.2026.122201_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-019-0339-2","article-title":"BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling","volume":"9","author":"Sheng","year":"2019","journal-title":"Cell Biosci."},{"issue":"5","key":"10.1016\/j.jep.2026.122201_bib32","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jep.2026.122201_bib34","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor \u03baB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jep.2026.122201_bib35","article-title":"Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications","volume":"12","author":"Xu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.jep.2026.122201_bib36","article-title":"Bile acid-mediated gut-liver axis crosstalk: the role of nuclear receptor signaling in dynamic regulation of inflammatory networks","volume":"16","author":"Yan","year":"2025","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.jep.2026.122201_bib37","first-page":"4953","article-title":"Babaodan capsules for viral hepatitis: systematic review of clinical efficacy and safety and meta-analysis of randomized clinical trials","volume":"44","author":"Yang","year":"2019","journal-title":"Zhongguo Zhongyao Zazhi"},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.122201_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ejmech.2012.12.062","article-title":"Recent advances in natural products from plants for treatment of liver diseases","volume":"63","author":"Zhang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jmcb\/mjy052","article-title":"The SLC transporter in nutrient and metabolic sensing, regulation, and drug development","volume":"11","author":"Zhang","year":"2019","journal-title":"J. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.jep.2026.122201_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12944-026-02867-9","article-title":"Dysregulation of the AMPK-SREBP1-FASN axis in MASLD: driving a vicious cycle of lipotoxicity and metabolic-immune crosstalk","volume":"25","author":"Zhao","year":"2026","journal-title":"Lipids Health Dis."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037887412601055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037887412601055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:31:06Z","timestamp":1790775066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037887412601055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":40,"alternative-id":["S037887412601055X"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.122201","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-\u03baB, and SLC22A7 in bile acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.122201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122201"}}